For a year, women around menopause took black cohosh or a dummy capsule; hot flashes did not differ.
Trial · in all five groups · 1 year · funding not stated
Newton et al., Annals of Internal Medicine, 2006
Terms and sources
- women around menopause
- 351 women aged 45 to 55, with 2 or more hot flashes or night sweats a day. 52% were in the menopausal transition.
- black cohosh
- 160 mg a day. NIH describes it as a 70% ethanol extract with 2.5% triterpene glycosides. Other groups took herbal mixtures or a hormone medicine.
- hot flashes did not differ
- Hot flashes and night sweats per day, their intensity, and a hot-flash scale, at 3, 6 and 12 months. The average difference from the dummy capsule was under 1 a day. Letters on this trial were published, with a reply. We could not read them. An editorial and other comments on this trial were also published; we could not read them.
- a dummy capsule
- The trial was double-blind.
- funding not stated
- PubMed's record notes NIH extramural research funding. We could not read the funding section of this paper.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
A trial in Washington State compared black cohosh, two herbal mixtures, a hormone medicine and a dummy capsule. 351 women aged 45 to 55 took them for a year. The black cohosh group took 160 mg a day. Hot flashes and night sweats per day did not differ from the dummy capsule at 3, 6 or 12 months. Their intensity did not differ either. With the hormone medicine, there were about 4 fewer a day than with the dummy capsule. Funding: we could not read the funding section.
Women around menopause: after 3 months, blood fats, sugar and insulin did not differ between black cohosh and dummy capsules.
Trial · in all five groups; 310 had blood measures · 3 months · funding not stated
Spangler et al., Maturitas, 2007
Same participants as Newton 2006
Terms and sources
- blood fats, sugar and insulin
- Total, LDL and HDL cholesterol, triglycerides, glucose, insulin and fibrinogen, measured in 310 women.
- black cohosh
- 160 mg a day, in the same trial as Newton 2006.
- funding not stated
- PubMed's record notes NIH extramural research funding. We could not read the funding section of this paper.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
This report of the same 351-woman trial looked at blood tests after 3 months. 310 women had them measured. Cholesterol, triglycerides, glucose and insulin changed no differently with black cohosh than with the dummy capsule. Fibrinogen appeared to rise with one herbal mixture. Its difference from the dummy capsule was not statistically significant. Funding: we could not read the funding section.
After a year, hormone levels and vaginal cell tests did not differ between black cohosh and dummy capsules.
Trial · in all five groups · 1 year · funding not stated
Reed et al., Menopause, 2008
Same participants as Newton 2006
Terms and sources
- hormone levels
- Estradiol, FSH, LH and SHBG, at the start and at 12 months, in 133 women after menopause.
- vaginal cell tests
- Vaginal cells and dryness at 3 and 12 months. Bleeding diaries in 313 women showed no difference either. An editorial on this report was also published; we could not read it. A letter on this report was published, with a reply. We could not read them.
- black cohosh
- 160 mg a day, in the same trial as Newton 2006.
- funding not stated
- PubMed's record notes NIH extramural research funding. We could not read the funding section of this paper.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
This report of the same trial looked at hormone levels and gynecological tests over a year. Vaginal cells, dryness and bleeding did not differ between black cohosh and the dummy capsule. In 133 women after menopause, estradiol, FSH and LH did not differ either. The hormone medicine group differed on these measures. Funding: we could not read the funding section.
In women with menopausal symptoms, scores fell more with Ze 450 than with a dummy tablet over 12 weeks.
Trial · 180 people · 12 weeks · maker-funded
Schellenberg et al., Evidence-Based Complementary and Alternative Medicine, 2012
Terms and sources
- women with menopausal symptoms
- 180 women aged 40 or over, from 4 clinics. A doctor confirmed menopausal complaints with a symptom score. About 23% had not reached menopause.
- Ze 450
- A 60% ethanol extract of rhizome and root, 6.5 mg or 13 mg a day. It came from Max Zeller Söhne AG, per the methods. Possibly related side effects: 5 with the dummy tablet, 2 with each dose.
- scores fell more
- Kupperman Index, a menopausal symptom score. Both doses differed from the dummy tablet; the difference was statistically significant and larger with 13 mg.
- a dummy tablet
- Identical-looking tablets; each group took two a day.
- maker-funded
- Funded by Max Zeller Söhne AG, named in the methods as the source of Ze 450. Three authors work for the company.
Study · Free full text · about 18 min to read
Our estimate at about 200 words a minute, from the PMC full text without tables.
Study summary
Women with menopausal complaints took 13 mg of Ze 450, 6.5 mg, or a dummy tablet for 12 weeks. 180 women aged 40 or over took part. Kupperman Index scores fell more with both doses than with the dummy tablet. The difference was larger with 13 mg. The score fell by half or more in 69% with 13 mg and 40% with 6.5 mg. With the dummy tablet, it did so in 7%. Side effects were few in all groups. Funding: Max Zeller Söhne AG, whose staff include three authors.
Women with daily hot flashes took Cr 99 or a dummy product for 12 weeks; scores did not differ.
Trial · randomized, per the Cochrane review; 122 in the intention-to-treat analysis · 12 weeks · funding not stated
Frei-Kleiner et al., Maturitas, 2005
Terms and sources
- daily hot flashes
- 3 or more hot flashes a day. 14 centers in Switzerland, per the Cochrane review.
- Cr 99
- A black cohosh root extract, as the abstract names it. 6.5 mg of dry extract a day, per the Cochrane review. The abstract does not name the maker. Side effects did not differ between the groups.
- scores did not differ
- Weekly hot-flash score and Kupperman Index, the two main measures. With a starting Kupperman Index of 20 or more, the Kupperman Index and Menopause Rating Scale differed. In that subgroup, the hot-flash score just missed statistical significance.
- a dummy product
- Capsules with excipients only, per the Cochrane review.
- funding not stated
- We could not read the funding section of this paper.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
129 women with 3 or more hot flashes a day were randomized. 122 were in the main analysis. They took the Cr 99 extract or a dummy product for 12 weeks. The two main measures did not differ between groups overall. With a starting Kupperman Index of 20 or more, the Kupperman Index and Menopause Rating Scale differed. The hot-flash score just missed statistical significance. Side effects did not differ. Funding: we could not read the funding section.
Over a year, hot flash counts did not differ from a dummy capsule; intensity was higher with black cohosh.
Trial · in all four groups · 12 months · maker-funded
Geller et al., Menopause, 2009
Terms and sources
- hot flash counts
- Hot flashes and night sweats per week, in 89 women with at least 35 a week. They fell 34% with black cohosh and 63% with the dummy capsule.
- intensity was higher
- Statistically significant at 6 and 9 months. At 3 months, Kupperman and Greene vasomotor scores were also higher with black cohosh.
- black cohosh
- 128 mg a day of an ethanol extract of the underground parts, with 7.27 mg of triterpene glycosides. Other groups took red clover or a hormone medicine. Liver tests and the other safety measures did not differ from the dummy capsule.
- a dummy capsule
- Rice powder in the same olive green capsule as the other groups.
- maker-funded
- Funded by NIH, with backing from Pharmavite to the University of Illinois Foundation. Pharmavite made the capsules and Pureworld the extract. One author was a paid consultant to Pharmavite.
Study · Free full text · about 21 min to read
Our estimate at about 200 words a minute, from the PMC full text without tables.
Study summary
89 women had at least 35 hot flashes or night sweats a week. For a year, they took black cohosh, red clover, a hormone medicine or a dummy capsule. Counts fell 34% with black cohosh and 63% with the dummy capsule. The difference was not statistically significant. Intensity was higher with black cohosh at 6 and 9 months. Liver tests did not differ between groups. Funding: NIH, with backing from Pharmavite to the University of Illinois Foundation. Pharmavite made the capsules and Pureworld the extract. One author was a paid consultant to Pharmavite.
After a year, memory and other thinking tests did not differ between black cohosh and a dummy capsule.
Trial · of 89 in the parent trial, all four groups · 12 months
Maki et al., Menopause, 2009
Same participants as Geller 2009
Terms and sources
- memory and other thinking tests
- Word-list and story recall, attention, verbal fluency, figure memory and spatial tests, before and in the 12th month. 26% of the parent trial's women were not in this analysis; the authors list this as a possible bias.
- black cohosh
- 128 mg a day, the same extract and women as in Geller 2009. Funded by NIH grants.
Study · Free full text · about 28 min to read
Our estimate at about 200 words a minute, from the PMC full text without tables.
Study summary
66 women from the Geller 2009 trial did memory and thinking tests before and after a year. Groups took black cohosh, red clover, a hormone medicine or a dummy capsule. No memory or other thinking test changed differently with black cohosh than with the dummy capsule. The hormone medicine group scored lower on one word-list measure. Funding: NIH grants.
Women after menopause took Cimifugol or a dummy tablet for 8 weeks; symptom scores fell more with Cimifugol.
Trial · 84 people · 8 weeks
Mohammad-Alizadeh-Charandabi et al., Chinese Medicine, 2013
Terms and sources
- Women after menopause
- 84 women aged 45 to 60 in Tehran, with Greene Climacteric Scale scores of 15 to 42.
- Cimifugol
- Tablets with 6.5 mg of dried root extract, bought at a pharmacy. Each held 0.12–0.18 mg of 27-deoxyactein. Funded by Tabriz University of Medical Sciences. The authors declare no competing interests.
- symptom scores fell more
- Total score and all four parts, including hot flashes, at 4 and 8 weeks. All differences were statistically significant. No side effects were reported in either group.
Study · Free full text · about 14 min to read
Our estimate at about 200 words a minute, from the PMC full text without tables.
Study summary
84 women after menopause in Tehran took part. Each night for 8 weeks, they took a 6.5 mg Cimifugol tablet or a dummy tablet. Greene Climacteric Scale scores fell more with Cimifugol at 4 and 8 weeks. All four parts of the scale differed, including hot flashes. No side effects were reported, and no one left the trial. Funding: Tabriz University of Medical Sciences. The authors declare no competing interests.
Women after menopause took BNO 1055 or a dummy product; symptom scores differed only in the 62 analyzed per protocol.
Trial · randomized; 62 analyzed, per the paper · 3 months · industry author
Wuttke et al., Maturitas, 2003
Terms and sources
- Women after menopause
- 97 women were randomized, for 3 months. A third group took a hormone medicine.
- BNO 1055
- Sold as Klimadynon or Menofem, the paper says. A 58% ethanol extract of the rhizome; the daily dose corresponds to 40 mg of herbal drug.
- symptom scores differed
- Menopause Rating Scale, the main measure. In the 62, scores fell more with BNO 1055 than with the dummy product. The hot flash items alone did not differ significantly. Superficial vaginal cells rose slightly with BNO 1055 and fell with the dummy product. The difference was not statistically significant.
- per protocol
- 2 left early, and 33 were excluded for hormone levels or weight outside the criteria. The paper says the analysis of all 97 randomized showed no significant differences between groups.
- industry author
- 1 of 3 authors worked for Bionorica AG. Grants from an EU program and the German Research Society paid for part of the work. The paper mentions a sponsor but does not name it.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
97 women after menopause were randomized to BNO 1055, a hormone medicine or a dummy product for 3 months. 2 left early, and 33 were excluded for hormone levels or weight outside the criteria. In the 62 analyzed, Menopause Rating Scale scores fell more with BNO 1055 than with the dummy product. The paper says the analysis of all 97 showed no significant differences between groups. Endometrial thickness did not change with BNO 1055. Superficial vaginal cells rose slightly with BNO 1055 and fell with the dummy product. That difference was not statistically significant. Funding: in part an EU program and the German Research Society. One author worked for Bionorica AG.
Thai women with menopausal symptoms took a black cohosh extract or a dummy product; symptom scores did not differ.
Trial · 54 people · funding not stated
Tanmahasamut et al., Climacteric, 2015
Terms and sources
- Thai women with menopausal symptoms
- 54 women aged 40 or over, at a university hospital menopause clinic, with moderate to severe Kupperman scores.
- a black cohosh extract
- 40 mg a day. The abstract does not name the brand or state how long the trial lasted.
- symptom scores did not differ
- Kupperman Index, hot flashes per day, quality of life and satisfaction. Liver tests did not change significantly.
- funding not stated
- PubMed's record notes research funding from outside the US government. We could not read the funding section of this paper.
Study · Abstract only · about 2 min to read
Abstract only; about 2 minutes.
Study summary
54 Thai women aged 40 or over had moderate to severe menopausal symptoms. They took 40 mg of black cohosh extract a day or a dummy product. Symptom scores and hot flashes fell over time in both groups. The differences between groups were not statistically significant. Liver tests did not change significantly. Funding: we could not read the funding section.